Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …

Simple Summary Pancreatic cancer poses a grave threat to mankind, due to its poor
prognosis and aggressive nature. An accurate diagnosis is critical for implementing a …

Recently, long non-coding RNAs (lncRNA) have been proven to regulate pancreatic cancer
(PC) progression. We aimed to explore the pathogenesis of LINC00941 in PC regarding …

Background The overall poor prognosis in pancreatic cancer is related to late clinical
detection. Early diagnosis remains a considerable challenge in pancreatic cancer …

Abstract Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the
main key to surviving cancer patients. Urine proteomic biomarkers which are creatinine …

Purpose: Amid the need for new approaches to improve survival in pancreatic ductal
adenocarcinoma (PDAC), immune-based therapies have garnered interest. Rintatolimod, a …

A global increase in the incidence of pancreatic cancer (PanCa) presents a major concern
and health burden. The traditional tissue-based diagnostic techniques provided a major way …

Background Pancreatic cancer is a lethal proliferative disease driven by multiple genetic
and epigenetic alterations. Microarrays and omics-based sequencing techniques are potent …

Given the limitation of current routine approaches for pancreatic cancer screening and
detection, the mortality rate of pancreatic cancer cases is still critical. The development of …

Pancreatic ductal adenocarcinoma (PDAC) is the solid tumor with the worst prognosis,
representing today the third cause of cancer-related deaths in developed countries and …